Internal Medicine Alert - May 30, 2005

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Subjects:

  • What You Can’t See Will Hurt You (and Your Patient)
  • Asymptomatic Mitral Regurgitation—When is it Appropriate to Repair or Replace?
  • Bad News About the COX-2 Inhibitors
  • Pharmacology Update: Micafungin Infusion (Mycamine)
  • Clinical Briefs

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens
  • Describe the pros and cons of new screening procedures

Financial Disclosure:

Internal Medicine Alert’s Editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca and serves on the speaker’s bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil.